Nature

Mergers and acquisitions articles from across Nature Portfolio

Mergers and acquisitions (M&A) involve the buying, selling, dividing and combining of different companies to achieve company goals. For example, in the pharmaceutical industry, large companies may acquire small companies with a view to enhancing the overall pipeline of potential medicines they are developing or to gain access to a proprietary technology.

News and Comment

Neurokinin 3 receptor antagonist revival heats up with Astellas acquisition
- Megan Cully
News31 May 2017 Nature Reviews Drug Discovery
Volume: 16, P: 377
Merck bets on purine receptor revival
- Megan Cully
News22 Jul 2016 Nature Reviews Drug Discovery
Volume: 15, P: 525
Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis
- Megan Cully
News03 May 2016 Nature Reviews Drug Discovery
Volume: 15, P: 301
Roche bets on bromodomains
- Eva von Schaper
News07 Apr 2016 Nature Biotechnology
Volume: 34, P: 361-362
Big-cap buying bonanza trickles down to small biotech
- Melanie Senior
News07 Nov 2014 Nature Biotechnology
Volume: 32, P: 1077-1078
GSK buys partner Human Genome Sciences
- Mark Ratner
News10 Sept 2012 Nature Biotechnology
Volume: 30, P: 815

All News & Comment

Search

Advanced search

Quick links